Beta-glucosidase Substrate for Clostridium difficile Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing Clostridium difficile infections are time-consuming and require technical expertise, with traditional techniques like toxin detection and bacterial culture taking 24 to 72 hours and often necessitating pure culture growth, which is not always feasible.
Innovation Solution
A reaction medium containing a beta-glucosidase substrate, such as Alizarin-β-glucoside or Magenta-β-glucoside, that allows for the rapid identification of Clostridium difficile by hydrolysis detection within 24 hours, facilitating quicker diagnosis and eliminating the need for pure culture growth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If traditional toxin detection or bacterial culture methods are used, then diagnostic reliability is maintained, but diagnostic time increases to 24-72 hours
Solution Approach 1:
The diagnostic process is segmented into two independent parts: (1) toxin detection using ELISA for rapid screening, and (2) bacterial culture for definitive identification. This segmentation allows the toxin detection to provide early results within hours while the culture process continues independently to confirm the diagnosis, thereby reducing overall diagnostic time without sacrificing reliability.
Solution Approach 2:
Toxin detection is performed as a preliminary action before final cultural confirmation. The ELISA test provides preliminary evidence of C. difficile infection within hours, allowing clinicians to initiate appropriate treatment earlier while the slower but definitive culture process continues in parallel to confirm the diagnosis.
2Measurement precision
If bacterial culture is performed to obtain pure culture growth, then identification accuracy is improved, but time consumption increases to 24-72 hours for sufficient biomass
Solution Approach 1:
Instead of waiting for complete pure culture growth to sufficient biomass levels (3-4 McFarland) which takes 24-72 hours, the method uses partial action by detecting toxins in the original sample or early culture stages using ELISA. This partial detection provides sufficient identification accuracy for clinical decision-making without requiring the excessive time for full biomass accumulation.
Solution Approach 2:
The ELISA test acts as an intermediary method between direct microscopic examination and full cultural identification. It provides a bridge that delivers accurate identification results within hours by detecting bacterial toxins, eliminating the need to wait for sufficient bacterial biomass to grow for traditional identification methods.
3Productivity
If toxin detection by ELISA is used, then diagnostic speed is improved, but the need for additional culture confirmation increases complexity
Solution Approach 1:
The diagnostic workflow is segmented into distinct sequential steps: ELISA toxin detection followed by selective culture on specific media (C. diff agar or CCFA agar). This segmentation organizes the complexity into manageable stages, where each step has a clear purpose and can be performed by different personnel, thereby improving diagnostic speed while making the overall complex process more systematic and manageable.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid and definitive identification of Clostridium difficile from biological samples within 24 hours, reducing diagnostic time and expertise requirements, while maintaining high specificity and sensitivity.
Implementation Method 1
detect the hydrolysis of the beta-glucosidase substrate indicating the presence of Clostridiurn difficile
Data Source
AI summary
The invention relates to a method for detecting and/or identifying Clostridium difficile, characterised in that it comprises the following steps: a) providing a reaction medium including at least one beta-glucosidase substrate adapted for the identification of C. difficile; b) seeding the medium with a biological sample to be tested; c) allowing for incubation; and d) detecting the hydrolysis of the beta-glucosidase substrate, indicative of the presence of Clostridium difficile. The invention also relates to a reaction medium for the detection and/or the identification of Clostridium difficile, that comprises at least one beta-glucosidase substrate adapted for the identification of C. difficile.